Modeling Drug-Carrier Interaction in the Drug Release from Nanocarriers
The model fit into release data. (a) Carboxylfluorescein from thermosensitive liposomes with different PEG addition . (b, c) Verapamil and doxorubicin from liposomes . (d) Amiodarone from LNC . (e) BSA from PLLA nanocapsules . (f) Indomethacin from PECL nanocapsules . Solid lines represent the model prediction.